Literature DB >> 15133404

Hypertension treatment in the ambulatory setting: comparison by race and gender in a national survey.

Denise E Bonds1, Shana Palla, Alain G Bertoni, Philip Mellen, David C Goff.   

Abstract

To determine if different therapies are used in different racial groups and by gender, data from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Care Survey (national probability samples of outpatient visits) were used. All visits for hypertension in 1999 and 2000 were reviewed. Survey weights were applied to obtain national estimates. Provision of therapies by gender and race/ethnicity (white, African American, Hispanic, Asian) was examined. Over 137 million visits for hypertension care were made during 1999 and 2000. Diet and exercise counseling were performed at a low percentage of visits (35% and 26% of visits, respectively). The most common antihypertensive agent prescribed was angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers (28%), while first-line drugs, diuretics (23%) and b blockers (15%), which are recommended by national committees, were prescribed less frequently. Asians and Hispanics were more likely to receive counseling on diet (Asians: odds ratio [OR], 2.29; 95% confidence interval [CI], 1.45-3.60; Hispanics: OR, 2.51; 95% CI, 1.18-5.33) and exercise (Asians: OR, 2.44; 95% CI, 1.35-4.42; Hispanics: OR, 3.28; 95% CI, 1.50-7.21) than non-Hispanic whites. African Americans were more likely to be prescribed calcium channel blockers (OR, 1.51; 95% CI, 1.20-1.91) and diuretics (OR, 1.37; 95% CI, 1.08-1.74). Low use of recommended therapies was found. Although variation by race was seen, it did not systematically favor groups associated with poor outcomes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133404      PMCID: PMC8109412          DOI: 10.1111/j.1524-6175.2004.03331.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  18 in total

1.  Ethnic aspects of hypertension.

Authors:  N M Kaplan
Journal:  Lancet       Date:  1994-08-13       Impact factor: 79.321

2.  A test of interventions to increase adherence to hypertensive medical regimens.

Authors:  J P Kirscht; J L Kirscht; I M Rosenstock
Journal:  Health Educ Q       Date:  1981

3.  Hypertension in black people: pathophysiology and therapeutic aspects.

Authors:  A A Lopes
Journal:  J Hum Hypertens       Date:  2002-03       Impact factor: 3.012

4.  Contribution of major diseases to disparities in mortality.

Authors:  Mitchell D Wong; Martin F Shapiro; W John Boscardin; Susan L Ettner
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

5.  Factors associated with hypertension control in the general population of the United States.

Authors:  Jiang He; Paul Muntner; Jing Chen; Edward J Roccella; Richard H Streiffer; Paul K Whelton
Journal:  Arch Intern Med       Date:  2002-05-13

6.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

7.  Barriers to hypertension care and control in young urban black men.

Authors:  M N Hill; L R Bone; M T Kim; D J Miller; C R Dennison; D M Levine
Journal:  Am J Hypertens       Date:  1999-10       Impact factor: 2.689

8.  Physician-related barriers to the effective management of uncontrolled hypertension.

Authors:  Susan A Oliveria; Pablo Lapuerta; Bruce D McCarthy; Gilbert J L'Italien; Dan R Berlowitz; Steven M Asch
Journal:  Arch Intern Med       Date:  2002-02-25

9.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991.

Authors:  V L Burt; P Whelton; E J Roccella; C Brown; J A Cutler; M Higgins; M J Horan; D Labarthe
Journal:  Hypertension       Date:  1995-03       Impact factor: 10.190

10.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  2 in total

1.  Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.

Authors:  Brian J Isetts; Daniel E Buffington; Barry L Carter; Marie Smith; Linnea A Polgreen; Paul A James
Journal:  Pharmacotherapy       Date:  2016-03-18       Impact factor: 4.705

2.  Colon cancer screening consultations may identify racial disparity in hypertension diagnosis and management.

Authors:  Mark Friedman; Marie L Borum
Journal:  J Natl Med Assoc       Date:  2007-05       Impact factor: 1.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.